Page 102 - MemoriaBBN-Eng

RESEARCH GROUPS

ááí
á

íáí

ñ
ñá
áá

áé
í

é
é

PROGRAMME:
Nanomedicine
Nanobiotechnology for Diagnostics (Nb4D)

Lead Researcher
Group Members

STAFF MEMBERS
Marco Colás, Ma Pilar
Babington, Ruth Jamie

íGarca Fernndez, Lorena
Contact:
Mendoza Santana, Marlene
Instituto de Qumica Avanzada de Cataluña. Salvador Vico, Juan Pablo
C/ Jordi Girona, 18-26. Barcelona.
Scheper , Johanna Katharina
E.mail: [email protected] · Website: www.iqac.csic.es/nb4d
Valera Cano, Enrique Andrs

ASSOCIATED MEMBERS
Galve Bosch, Roger Main lines of research

Gonzlez Pinacho, Daniel The Nanobiotechnology for Diagnostics (Nb4D) research group has been recognized
Muriano Castaon, Alejandro
and awarded by the Catalonian Government since 2005. The general objective of its
Pascual Durn, Nuria research is the investigation of new approaches and strategies to improve the ef-
Snchez Baeza, Fco. Jos
ficiency of current diagnostic methods. To achieve this goal the research addresses
three fundamental specific objectives:
CONTRIBUTORS
Broto Avils, Marta • The development and characterization of bioreceptors with tailored properties.

Colom Sanmart, Gloria • The preparation of biohybrid functional materials resulting from the incorporation of
Garca Fernndez, Lorena specific bioreceptors on micro/ nanostructured materials and devices

Gonzlez Gonzlez, Ana Rosa • The investigation of new nanobiotecnological approaches for the development of a
Hernndez Albors, Alejandro
new generation of tools and devices that increase the effectiveness of diagnosis in
Pastells Diez, Carme the clinical, food and environmental fields.
13
Petanas Esteban, Salvador The scientific activity of the group started on year 1996 particularly focused on the 20
Rodrguez Nuez, Montserrat
T
development of antibodies and on the establishment of immunochemical methods. In R
this respect, the group has an important collection of immunoreagents for environ- PO
mental pollutants including endocrine disruptors, pesticides or pharmaceuticals. The E
L R
group is running the CAbS (Custom Antibody Service), a facility that provides internal A
and external services addressed to develop immunoreagents and provide scientific NU
N
support in the immunodiagnostic field. Since more than eight years the scientific A
objectives have been expanded to the biosensor and nanobiotechnology fields. The /
BN
associated increase of the know-how, expertise and capabilities of the Nb4D group B
has been achieved through its participation in a significant number of Spanish and R-
BE
FP European research projects (FP4-FP7: INEXsPORT- ENV4-CT97-0476, TECACOR- CI
FAIR-CT98-9586; RADAR-GLK1-CT-2001-01670, ELISHA- NMP2-CT-2003-505485,
102
GOODFOOD- IST-2003-508774, Conffidence-KBBE-2008-211326, CAJAL4EU- ICT-